Vishal R. Dhere

684 total citations
29 papers, 211 citations indexed

About

Vishal R. Dhere is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vishal R. Dhere has authored 29 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiation and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vishal R. Dhere's work include Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (16 papers) and Advanced Radiotherapy Techniques (9 papers). Vishal R. Dhere is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (16 papers) and Advanced Radiotherapy Techniques (9 papers). Vishal R. Dhere collaborates with scholars based in United States, India and South Africa. Vishal R. Dhere's co-authors include Pretesh Patel, Bruce Hershatter, Ashesh B. Jani, Shreyas Joshi, Subir Goyal, Viraj A. Master, David M. Schuster, Peter J. Rossi, Mark M. Goodman and Mehmet Asım Bilen and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Vishal R. Dhere

21 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vishal R. Dhere United States	7	132	95	45	32	31	29	211
Carmen González‐San Segundo Spain	7	134 1.0×	46 0.5×	31 0.7×	80 2.5×	17 0.5×	22	185
Abdulredha Esmail Kuwait	8	105 0.8×	150 1.6×	33 0.7×	46 1.4×	9 0.3×	24	229
Fabio Matrone Italy	8	94 0.7×	63 0.7×	52 1.2×	46 1.4×	15 0.5×	29	183
Jennifer Le Guévelou France	9	98 0.7×	60 0.6×	36 0.8×	51 1.6×	22 0.7×	33	186
S. Voruganti Canada	5	88 0.7×	63 0.7×	37 0.8×	80 2.5×	55 1.8×	10	192
Iosif Strouthos Germany	10	182 1.4×	119 1.3×	21 0.5×	111 3.5×	16 0.5×	23	289
Marcin Hetnał Poland	10	83 0.6×	29 0.3×	36 0.8×	46 1.4×	12 0.4×	24	165
Detlef Imhoff Germany	9	89 0.7×	68 0.7×	24 0.5×	88 2.8×	22 0.7×	18	215
Sarit Appel Israel	7	146 1.1×	81 0.9×	56 1.2×	73 2.3×	15 0.5×	28	208
Damaris Patricia Rojas Italy	9	136 1.0×	74 0.8×	35 0.8×	136 4.3×	74 2.4×	22	279

Countries citing papers authored by Vishal R. Dhere

Since Specialization

Citations

This map shows the geographic impact of Vishal R. Dhere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishal R. Dhere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishal R. Dhere more than expected).

Fields of papers citing papers by Vishal R. Dhere

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishal R. Dhere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishal R. Dhere. The network helps show where Vishal R. Dhere may publish in the future.

Co-authorship network of co-authors of Vishal R. Dhere

This figure shows the co-authorship network connecting the top 25 collaborators of Vishal R. Dhere. A scholar is included among the top collaborators of Vishal R. Dhere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishal R. Dhere. Vishal R. Dhere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Sagar A., Marly van Assen, Stephanie Cantu, et al.. (2026). Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer. JAMA Cardiology.

Jani, Ashesh B., Vishal R. Dhere, Subir Goyal, et al.. (2025). Initial report of a randomized trial of post-prostatectomy prostate cancer radiotherapy using either fluciclovine ( ¹⁸ F) or PSMA ( ⁶⁸ Ga) PET/CT for target dose-escalation.. Journal of Clinical Oncology. 43(5_suppl). 326–326.

Patel, Sagar A., Chih‐Wei Chang, Vishal R. Dhere, et al.. (2025). The effect of interfractional variation on delivered dose with ultrahypofractionated pencil beam scanning proton therapy for localized prostate cancer. Journal of Applied Clinical Medical Physics. 26(9). e70223–e70223.

Sebastian, Nikhil, Dattatraya Patil, Pretesh Patel, et al.. (2025). Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States. Cancer. 131(6). e35795–e35795. 2 indexed citations

Lawal, Ismaheel O., Ashesh B. Jani, Vishal R. Dhere, et al.. (2025). Diuresis During¹⁸F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial. Journal of Nuclear Medicine. 66(2). 230–237.

Dhere, Vishal R., David M. Schuster, Subir Goyal, et al.. (2025). Volumetric Changes and Acute Toxicity With 68Ga Prostate-Specific Membrane Antigen Versus 18F-Fluciclovine Positron Emission Tomography/Computer Tomography Guided Postprostatectomy Radiation: Final Analysis of a Randomized Trial. Practical Radiation Oncology. 16(1). e38–e46.

Patel, Sagar A., Subir Goyal, Yuan Liu, et al.. (2024). Relugolix versus leuprolide in combination with radiotherapy for localized prostate cancer (REVELUTION trial): An initial analysis of patient treatment preferences and quality of life.. Journal of Clinical Oncology. 42(4_suppl). 301–301. 1 indexed citations

Connolly, Erin C., Tony Pan, Maneesha Aluru, et al.. (2024). Loss of immune cell identity with age inferred from large atlases of single cell transcriptomes. Aging Cell. 23(12). e14306–e14306.

Dhere, Vishal R., Sharad Goyal, Jun Zhou, et al.. (2024). Impact of Rectal Spacer on Toxicity Reduction in Men Treated With Proton Versus Photon Therapy. International Journal of Particle Therapy. 13. 100111–100111.

10.

Lawal, Ismaheel O., Charles Marcus, David M. Schuster, et al.. (2023). Impact of 18F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Clinical Nuclear Medicine. 48(4). e153–e159. 6 indexed citations

11.

Sebastian, Nikhil, Subir Goyal, Yuan Liu, et al.. (2023). Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy. JAMA Network Open. 6(8). e2327637–e2327637. 2 indexed citations

12.

Dhere, Vishal R., David M. Schuster, Subir Goyal, et al.. (2022). Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography–Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects. International Journal of Radiation Oncology*Biology*Physics. 113(5). 1003–1014. 2 indexed citations

13.

Lawal, Ismaheel O., Ashesh B. Jani, Subir Goyal, et al.. (2022). Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus¹⁸F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial. Journal of Nuclear Medicine. 64(4). 586–591. 5 indexed citations

14.

Jani, Ashesh B., Eduard Schreibmann, Subir Goyal, et al.. (2021). 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. The Lancet. 397(10288). 1895–1904. 103 indexed citations

15.

Dhere, Vishal R., Benjamin W. Fischer‐Valuck, Sharad Goyal, et al.. (2021). Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer. Brachytherapy. 20(6). 1130–1138. 6 indexed citations

16.

Schreibmann, Eduard, Sharad Goyal, Bruce Hershatter, et al.. (2020). Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(5). 1397–1397. 9 indexed citations

17.

Hess, Clayton B., Tahseen H. Nasti, Vishal R. Dhere, et al.. (2020). Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia. International Journal of Radiation Oncology*Biology*Physics. 109(4). 867–879. 34 indexed citations

18.

Dhere, Vishal R., Sibo Tian, Zachary S. Buchwald, et al.. (2020). Moderately Hypofractionated Radiation for Benign Meningiomas and Schwannomas: A Report of 70 Patients Treated Between 2008 and 2018. Advances in Radiation Oncology. 5(6). 1147–1151. 4 indexed citations

19.

Dhere, Vishal R., Scott Edelman, Edmund K. Waller, et al.. (2017). Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. Leukemia & lymphoma. 59(4). 837–843. 8 indexed citations

20.

Dhere, Vishal R., et al.. (2013). A Practical and Novel Method to Extract Genomic DNA from Blood Collection Kits for Plasma Protein Preservation. Journal of Visualized Experiments. e4241–e4241. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact